GeNeuro Appoints Dr. Gordon Francis And Giacomo Di Nepi To Board Of Directors
GENEVA & LYON, France--(BUSINESS WIRE)--GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that Gordon S. Francis, MD, and Giacomo Di Nepi have agreed to join its Board of Directors.
“We feel privileged and honored to have Gordon and Giacomo, two extremely well-respected industry leaders, join our Board,” said Jesùs Martin-Garcia, Chairman of GeNeuro. “Gordon’s expertise in developing novel treatments against MS will help GeNeuro in moving the development of GNbAC1, the first drug addressing a causal factor of the disease, through its next stages of clinical development.”
Help employers find you! Check out all the jobs and post your resume.
“We feel privileged and honored to have Gordon and Giacomo, two extremely well-respected industry leaders, join our Board,” said Jesùs Martin-Garcia, Chairman of GeNeuro. “Gordon’s expertise in developing novel treatments against MS will help GeNeuro in moving the development of GNbAC1, the first drug addressing a causal factor of the disease, through its next stages of clinical development.”
Help employers find you! Check out all the jobs and post your resume.